Variant report
Variant | esv3693099 |
---|---|
Chromosome Location | chr11:104923951-104930676 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs508760 | chr11:104923951-104923952 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs499695 | chr11:104923963-104923964 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs140552431 | chr11:104923992-104923993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577243444 | chr11:104924020-104924021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577019348 | chr11:104924021-104924022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112392257 | chr11:104924083-104924084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142160274 | chr11:104924118-104924119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs501422 | chr11:104924125-104924126 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs561933025 | chr11:104924148-104924149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572240940 | chr11:104924165-104924166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575049057 | chr11:104924186-104924187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150859943 | chr11:104924210-104924211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139295907 | chr11:104924225-104924226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1785883 | chr11:104924246-104924247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543074770 | chr11:104924319-104924320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562949683 | chr11:104924330-104924331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183499324 | chr11:104924344-104924345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150002871 | chr11:104924366-104924367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568643841 | chr11:104924370-104924371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375347237 | chr11:104924380-104924381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547670457 | chr11:104924429-104924430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146552400 | chr11:104924472-104924473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115033740 | chr11:104924500-104924501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141179499 | chr11:104924501-104924502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12288313 | chr11:104924520-104924521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570086157 | chr11:104924541-104924542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535812886 | chr11:104924556-104924557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143904278 | chr11:104924575-104924576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572248652 | chr11:104924666-104924667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541263087 | chr11:104924684-104924685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558611801 | chr11:104924702-104924703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189401071 | chr11:104924704-104924705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146877540 | chr11:104924709-104924710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562441 | chr11:104924786-104924787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs148991853 | chr11:104924791-104924792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528890226 | chr11:104924807-104924808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143755852 | chr11:104924837-104924838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562452305 | chr11:104924871-104924872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527968387 | chr11:104924902-104924903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182547633 | chr11:104924937-104924938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563562 | chr11:104924938-104924939 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs187159949 | chr11:104924965-104924966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148132350 | chr11:104924966-104924967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12800151 | chr11:104924978-104924979 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs535900780 | chr11:104924995-104924996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12798696 | chr11:104924996-104924997 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs570444593 | chr11:104925041-104925042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546831692 | chr11:104925045-104925046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547005323 | chr11:104925051-104925052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140211629 | chr11:104925053-104925054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:104916800-104924400 | Weak transcription | Left Ventricle | heart |
2 | chr11:104918200-104925200 | Weak transcription | Ovary | ovary |
3 | chr11:104921400-104924600 | Enhancers | HepG2 | liver |
4 | chr11:104924400-104924600 | Enhancers | Left Ventricle | heart |
5 | chr11:104924600-104927000 | Weak transcription | HepG2 | liver |
6 | chr11:104925600-104926400 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr11:104926400-104931600 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
8 | chr11:104927000-104929200 | Enhancers | HepG2 | liver |
9 | chr11:104927000-104936200 | Weak transcription | Small Intestine | intestine |
10 | chr11:104928400-104928800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr11:104929200-104930200 | Weak transcription | HepG2 | liver |